Xian Ju Pharmaceutical (002332.SZ) and related personnel have received a warning letter from the Zhejiang Securities Regulatory Bureau.

The Wise Finance and Economics APP news reported that Xianju Pharmaceutical (002332.SZ) announced that the company recently received an administrative regulatory decision from the Zhejiang Regulatory Bureau of the China Securities Regulatory Commission, titled "Decision on Issuing a Warning Letter to Zhejiang Xianju Pharmaceutical Co., Ltd. and Related Personnel."